Sangamo Therapeutics Stock (NASDAQ: SGMO) stock price, news, charts, stock research, profile.
You can purchase shares of Sangamo Therapeutics (NASDAQ:SGMO) through any online brokerage.
Other companies in Sangamo Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Larimar Therapeutics (NASDAQ:LRMR), Tevogen Bio Holdings (NASDAQ:TVGN), Eledon Pharma (NASDAQ:ELDN) and Anika Therapeutics (NASDAQ:ANIK).
Sangamo Therapeutics has a consensus price target of $5.17.
The stock price for Sangamo Therapeutics (NASDAQ: SGMO) is $1.1601 last updated February 7, 2025 at 7:57 PM EST.
There are no upcoming dividends for Sangamo Therapeutics.
Sangamo Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Sangamo Therapeutics.
Sangamo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.